[go: up one dir, main page]

WO2002058673A8 - Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine - Google Patents

Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine

Info

Publication number
WO2002058673A8
WO2002058673A8 PCT/EP2002/000515 EP0200515W WO02058673A8 WO 2002058673 A8 WO2002058673 A8 WO 2002058673A8 EP 0200515 W EP0200515 W EP 0200515W WO 02058673 A8 WO02058673 A8 WO 02058673A8
Authority
WO
WIPO (PCT)
Prior art keywords
intestine
conveying
dietary compositions
preparing pharmaceutical
labile substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/000515
Other languages
French (fr)
Other versions
WO2002058673A1 (en
Inventor
Sergio Cecchetti
Valter Gatti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Giuliani SpA
Original Assignee
Giuliani SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani SpA filed Critical Giuliani SpA
Publication of WO2002058673A1 publication Critical patent/WO2002058673A1/en
Anticipated expiration legal-status Critical
Publication of WO2002058673A8 publication Critical patent/WO2002058673A8/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Method of preparation of pharmaceutical or dietary compositions comprising a polysaccharide, a phospholipid and an active principle, characterized in that it comprises the following stages: a) dry mixing of the said polysaccharide, phospholipid and active principle; b) adding an aqueous solution containing a pH buffer, in a smaller amount by weight relative to the dry mixture obtained in the said stage a) and in a ratio not greater than 1:3, thus forming moist granules; c) drying of the said moist granules, thus obtaining the said compositions in the form of powder.
PCT/EP2002/000515 2001-01-26 2002-01-17 Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine Ceased WO2002058673A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20010141 ITMI20010141A1 (en) 2001-01-26 2001-01-26 PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL OR DIETETIC COMPOSITIONS FOR VEHICULATION IN THE INTESTINE OF LABILE SUBSTANCES
ITMI01A000141 2001-01-26

Publications (2)

Publication Number Publication Date
WO2002058673A1 WO2002058673A1 (en) 2002-08-01
WO2002058673A8 true WO2002058673A8 (en) 2004-05-27

Family

ID=11446605

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/000515 Ceased WO2002058673A1 (en) 2001-01-26 2002-01-17 Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine

Country Status (2)

Country Link
IT (1) ITMI20010141A1 (en)
WO (1) WO2002058673A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007003718A (en) * 2004-09-27 2007-04-23 Cargill Inc Cyclodextrin inclusion complexes and methods of preparing same.
USD736382S1 (en) 2011-09-08 2015-08-11 Ams Research Corporation Surgical indicator with backers
CN115349639B (en) * 2022-10-17 2023-04-14 天津市宝恒生物科技有限公司 Probiotic slow-release system for improving immunity and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE159426T1 (en) * 1991-04-16 1997-11-15 Nippon Shinyaku Co Ltd METHOD FOR PRODUCING A SOLID DISPERSION
DE19619222A1 (en) * 1996-05-13 1997-11-20 Solvay Enzymes Gmbh & Co Kg Enzyme granules for food technology applications
WO2000004880A1 (en) * 1998-07-23 2000-02-03 Novo Nordisk A/S A wet granulation method for preparing a stable pharmaceutical formulation
US6340669B1 (en) * 1999-01-22 2002-01-22 Hunza Di Maria Carmela Marazzita S.A.S. Lipoprotein complexes and compositions containing them
DE60019784D1 (en) * 1999-10-29 2005-06-02 Hunza Di Pistolesi Elvira E C FIBROUS LIPO NUTRITION COMPLEXES AND COMPOSITIONS CONTAINING THEREOF

Also Published As

Publication number Publication date
WO2002058673A1 (en) 2002-08-01
ITMI20010141A1 (en) 2002-07-26

Similar Documents

Publication Publication Date Title
RU2367412C2 (en) Saturated powder that improves bioavailability and/or solubility of active substance, and method for making thereof
WO2002101412A3 (en) Spray freeze-dried compositions
WO2001049274A3 (en) Methods for pulmonary delivery of interleukin-2
PL345163A1 (en) Sitostand formulation with emulsifier to reduce cholesterol absorption
WO2004105504A3 (en) Dietary supplements and methods of preparing and administering dietary supplements
ES2237492T3 (en) METHOD FOR PREPARING ORTHOSILITIC ACID, ORTHOSILICICAL ACID AS OBTAINED AND ITS USE.
RU2001101910A (en) METHOD OF OBTAINING LIPOS
EA200301275A1 (en) CAPSULES FOR INHALATION
MXPA04004730A (en) Pharmaceutical compositions in particulate form.
HRP20050639A2 (en) Novel dry powder inhalation system for transpulmonary administration
WO2004050058A3 (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
PL343342A1 (en) Particulate active agent support for pulmonary application
CA2413698A1 (en) Endoparasiticidal agents for voluntary oral ingestion by animals
AU1381697A (en) Method for preparation of active substances from nacre, resulting products, useful in medicinal applications
WO2002043706A3 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
WO2002056881A8 (en) Fenofibrate tablets
MXPA04000211A (en) Granulates containing liposoluble substances and a process for the preparation thereof.
WO2002058673A8 (en) Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine
US7189416B2 (en) Method for stable and controlled delivery of (-)-hydroxycitric acid
AU2003296602A1 (en) Quaternary compounds comprising propolis as the active substance
AU2003224107A1 (en) Soluble composition containing sporopollenin and the use thereof
HUP0402093A3 (en) 3-phenyl-2-phenethylthio-propionic acid derivatives as selective agonists of ppar-alpha, their preparation and pharmaceutical compositions containing them
IL200447A0 (en) Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
CA2406269A1 (en) Process for drying amoxicillin
PT1755558T (en) Dry powder pharmaceutical composition, its preparation process and stable aqueous suspension obtained from such composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct app. not ent. europ. phase
WR Later publication of a revised version of an international search report
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP